Michael A Moskowitz

Professor of Neurology · Harvard Medical School, Massachusetts General Hospital · company speakers →

Michael Moskowitz is a professor of neurology at Harvard and Massachusetts General Hospital (MGH). He trained as an internist at Yale and as a neurologist at Harvard Longwood and has dedicated his 50-year career to translational research. His lab is credited with conceiving and conceptualising the neuropeptide-containing trigeminovascular pathway (TVS) as a migraine treatment target. Along with collaborators, he discovered the sensory innervation to the circle of Willis and its first neuropeptide, inhibition of peptide release as an ergot/triptan mechanism, spreading depression as an upstream trigger for TVS activation, and recently, CSF-containing bony skull channels that appear to convey bidirectional signaling between the brain/meninges/skull bone marrow.

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Congress of the European Academy of Neurology

27 June 2026 Geneva, Switzerland “The trigeminovascular system as a template for discovery in migraine”

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →